WMSA
CLVS

Weiss Multi-Strategy Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-66,000
Closed -$385K – 829
2020
Q3 		$385K Buy
66,000
+666
+1% +$3.98K 0.01% 499
2020
Q2 		$441K Buy
65,334
+21,701
+50% +$164K 0.01% 475
2020
Q1 		$278K Sell
43,633
-24,367
-36% -$195K 0.01% 376
2019
Q4 		$709K Buy
68,000
+3,000
+5% +$21.8K 0.01% 516
2019
Q3 		$255K Buy
65,000
+5,000
+8% +$40.4K 0.01% 529
2019
Q2 		$892K Buy
60,000
+30,000
+100% +$542K 0.02% 384
2019
Q1 		$745K Buy
30,000
+10,000
+50% +$251K 0.02% 414
2018
Q4 		$359K Sell
20,000
-1,231
-6% -$25.2K 0.01% 375
2018
Q3 		$624K Buy
21,231
+92
+0.4% +$3.56K 0.02% 426
2018
Q2 		$961K Buy
21,139
+1,839
+10% +$89.4K 0.02% 443
2018
Q1 		$1.02M Sell
19,300
-5,700
-23% -$333K 0.03% 418
2017
Q4 		$1.7M Sell
25,000
-5,000
-17% -$350K 0.04% 370
2017
Q3 		$2.47M Buy
30,000
+13,000
+76% +$1.03M 0.09% 276
2017
Q2 		$1.59M Sell
17,000
-5,000
-23% -$306K 0.07% 323
2017
Q1 		$1.4M Buy
+22,000
New +$1.34M 0.06% 344

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CLVS Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 66,000 shares — an estimated $385K sold.

Weiss Multi-Strategy Advisers first reported a position in CLVS in Q1 2017 and held it in 15 quarters. The position peaked at $2.47M in Q3 2017. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 66,000 Clovis Oncology, Inc. shares in Q4 2020, an estimated $385K.
  • Weiss Multi-Strategy Advisers first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 15 quarters.
  • Weiss Multi-Strategy Advisers's Clovis Oncology, Inc. position peaked at $2.47M in Q3 2017.
  • 159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.